These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10440163)

  • 1. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
    Borries M; Heins M; Fischer Y; Stiegler H; Peters A; Reinauer H; Schoebel FC; Strauer BE; Leschke M
    J Am Coll Cardiol; 1999 Aug; 34(2):486-93. PubMed ID: 10440163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
    Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
    Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
    Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
    Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty.
    Tahara A; Kohno M; Yanagi S; Itagane H; Toda I; Akioka K; Teragaki M; Yasuda M; Takeuchi K; Takeda T
    Metabolism; 1991 Dec; 40(12):1235-7. PubMed ID: 1961113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of coagulation and platelet activation in coronary sinus blood induced by transcatheter coronary intervention for narrowing of the left anterior descending coronary artery.
    Mizuno O; Hojo Y; Ikeda U; Katsuki T; Fukazawa H; Kurosaki K; Fujikawa H; Shimada K
    Am J Cardiol; 2000 Jan; 85(2):154-60. PubMed ID: 10955369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
    Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
    Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
    Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of a prothrombotic state in restenotic patients?
    Brack MJ; More RS; Pringle S; Gershlick AH
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures.
    Gregorini L; Marco J; Fajadet J; Bernies M; Cassagneau B; Brunel P; Bossi IM; Mannucci PM
    J Am Coll Cardiol; 1997 Jan; 29(1):13-20. PubMed ID: 8996289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.
    van den Bos AA; Deckers JW; Heyndrickx GR; Laarman GJ; Suryapranata H; Zijlstra F; Close P; Rijnierse JJ; Buller HR; Serruys PW
    Circulation; 1993 Nov; 88(5 Pt 1):2058-66. PubMed ID: 8222099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute coronary vessel occlusion after PTCA--possibility of risk stratification using quantitative coronary angiography, clinical determinants and laboratory chemistry parameters].
    Heidland UE; Klimek WJ; Michel CJ; Willers R; Heintzen MP; Strauer BE
    Z Kardiol; 1997 Dec; 86(12):982-9. PubMed ID: 9499496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty.
    Vaitkus PT; Watkins MW; Witmer WT; Tracy RP; Sobel BE
    Coron Artery Dis; 1995 Jul; 6(7):587-92. PubMed ID: 7582198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated clotting times in acute coronary syndromes and percutaneous transluminal coronary angioplasty.
    Wilson JM; Dougherty KG; Ellis KO; Ferguson JJ
    Cathet Cardiovasc Diagn; 1995 Jan; 34(1):1-5. PubMed ID: 7728844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
    Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
    Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.
    Bittl JA; Ahmed WH
    Am J Cardiol; 1998 Oct; 82(8B):50P-56P. PubMed ID: 9809892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty.
    Goudevenos J; Tselepis AD; Vini MP; Michalis L; Tsoukatos DC; Elisaf M; Ninio E; Sideris DA
    Eur J Clin Invest; 2001 Jan; 31(1):15-23. PubMed ID: 11168434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local changes in the plasma endothelin level in the coronary artery immediately after percutaneous transluminal coronary angioplasty.
    Vojácek J; Lisý O; Simek S; Kmonícek P; Rohác J; Jáchymová M; Jindra A
    Cardiology; 1997; 88(1):1-5. PubMed ID: 8960617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired fibrinolysis determines the outcome of percutaneus transluminal coronary angioplasty (PTCA).
    Fornitz GG; Nielsen P; Amtorp O; Kassis E; Abildgård U; Sloth C; Winther K; Ørskov H; Dalsgård J; Husted S
    Eur J Clin Invest; 2001 Jul; 31(7):586-92. PubMed ID: 11454013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: a comparison between drug-eluting and bare metal stents.
    Mahemuti A; Meneveau N; Seronde MF; Schiele F; Descotes-Genon V; Ecarnot F; Blonde MC; Mercier M; Racadot E; Bassand JP
    J Thromb Thrombolysis; 2009 Oct; 28(3):333-41. PubMed ID: 18766300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.